Delivra Health Brands Inc.
DHBUF
$0.20
$0.000.74%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 20.19% | -5.33% | 30.57% | -15.27% | 6.14% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 20.19% | -5.33% | 30.57% | -15.27% | 6.14% |
| Cost of Revenue | 14.19% | -5.33% | 50.01% | -12.01% | 30.38% |
| Gross Profit | 25.93% | -5.32% | 13.91% | -18.24% | -9.89% |
| SG&A Expenses | -15.85% | 1.69% | 24.17% | 25.21% | 21.74% |
| Depreciation & Amortization | -11.75% | -6.04% | -2.80% | -4.02% | -4.47% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.01% | -2.39% | 30.34% | 3.20% | 22.59% |
| Operating Income | 254.01% | -47.97% | -29.40% | -247.89% | -261.58% |
| Income Before Tax | -67.47% | -40.54% | -21.61% | -308.01% | 25,726.67% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -67.47% | -40.54% | -21.61% | -308.01% | 25,726.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -67.47% | -40.54% | -21.61% | -308.01% | 25,726.67% |
| EBIT | 254.01% | -47.97% | -29.40% | -247.89% | -261.58% |
| EBITDA | 8,463.64% | -71.65% | -93.83% | -113.04% | -98.31% |
| EPS Basic | -60.00% | -40.30% | -3.33% | -274.63% | 15,100.00% |
| Normalized Basic EPS | 419.23% | -40.48% | -3.57% | -287.18% | 84.34% |
| EPS Diluted | -60.00% | -40.30% | -3.33% | -274.63% | 15,100.00% |
| Normalized Diluted EPS | 419.23% | -40.48% | -3.57% | -287.18% | 84.34% |
| Average Basic Shares Outstanding | -18.75% | 0.00% | 17.90% | 19.00% | 52.32% |
| Average Diluted Shares Outstanding | -18.75% | 0.00% | 17.90% | 19.00% | 52.32% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |